Psychemedics Corporation (PMD)
USD 2.67
(0.0%)
USD 2.67
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.48 Million | 4.89 Million | 414 Thousand | -4.08 Million | 4.3 Million | 7.92 Million |
| Net Income | -4.15 Million | -1.08 Million | -665 Thousand | -3.85 Million | 1.54 Million | 4.58 Million |
| Depreciation & Amortization | 2.67 Million | 3.31 Million | 3.69 Million | 3.62 Million | 2.91 Million | 3.06 Million |
| Deferred income taxes | 691 Thousand | -531 Thousand | -371 Thousand | -339 Thousand | -405 Thousand | -288 Thousand |
| Stock-based compensation | 908 Thousand | 872 Thousand | 743 Thousand | 563 Thousand | 759 Thousand | 594 Thousand |
| Change in working capital | -1.72 Million | 2.31 Million | -802 Thousand | -4.16 Million | -534 Thousand | 11 Thousand |
| Other non-cash items | 131 Thousand | 5.33 Million | -2.18 Million | 94 Thousand | 33 Thousand | -35 Thousand |
| Investing Cash Flow | -159 Thousand | -208 Thousand | -220 Thousand | -858 Thousand | 2.07 Million | -5.35 Million |
| Investments in PPE | -159 Thousand | -187 Thousand | -182 Thousand | -991 Thousand | -1.73 Million | -1.32 Million |
| Acquisitions | - | - | - | 140 Thousand | - | - |
| Investment purchases | - | - | - | - | - | -4.03 Million |
| Sales/Maturities of investments | - | - | - | - | 3.81 Million | - |
| Other Investing Activities | -2000.00 | -21 Thousand | -38 Thousand | -7000.00 | 3.75 Million | -4.16 Million |
| Financing Cash Flow | -1.14 Million | -1.92 Million | -1.03 Million | 501 Thousand | -3 Million | -5.63 Million |
| Debt repayment | -294 Thousand | -664 Thousand | -688 Thousand | -678 Thousand | -415 Thousand | -1.74 Million |
| Dividends payments | -799 Thousand | -1.18 Million | -279 Thousand | -993 Thousand | -3.97 Million | -3.79 Million |
| Common Stock Repurchased | -54 Thousand | -78 Thousand | -72 Thousand | -9000.00 | -33 Thousand | -93 Thousand |
| Common Stock Issuance | - | - | 72 Thousand | -9000.00 | -33 Thousand | - |
| Other Financing Activities | -54 Thousand | 4000.00 | -68 Thousand | 2.19 Million | 1.44 Million | -93 Thousand |
| Accounts receivables | 373 Thousand | 377 Thousand | -760 Thousand | 424 Thousand | 1.04 Million | -355 Thousand |
| Accounts payables | 304 Thousand | -546 Thousand | 417 Thousand | -281 Thousand | -494 Thousand | 77 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.4 Million | 2.48 Million | -459 Thousand | -4.31 Million | -1.08 Million | 289 Thousand |
| Cash at beginning of period | 4.75 Million | 1.99 Million | 2.83 Million | 7.28 Million | 4.06 Million | 8.16 Million |
| Cash at end of period | 1.96 Million | 4.75 Million | 1.99 Million | 2.83 Million | 7.28 Million | 4.06 Million |
| Capital Expenditure | -159 Thousand | -187 Thousand | -182 Thousand | -991 Thousand | -1.73 Million | -1.32 Million |
| Effect of forex changes on cash | - | - | - | -10 Thousand | -170 Thousand | -1.02 Million |
| Net cash flow / Change in cash | -2.78 Million | 2.75 Million | -841 Thousand | -4.45 Million | 3.21 Million | -4.09 Million |
| Free Cash Flow | -1.63 Million | 4.7 Million | 232 Thousand | -5.07 Million | 2.57 Million | 6.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -827 Thousand | -688 Thousand | -4.15 Million | -945 Thousand | -2.09 Million | -726 Thousand |
| Depreciation & Amortization | 664 Thousand | 551 Thousand | 2.67 Million | 575 Thousand | 685 Thousand | 696 Thousand |
| Deferred income taxes | - | - | 691 Thousand | -7000.00 | 1.29 Million | -593 Thousand |
| Stock-based compensation | 287 Thousand | 297 Thousand | 908 Thousand | 187 Thousand | 401 Thousand | 143 Thousand |
| Change in working capital | -4000.00 | -633 Thousand | -1.72 Million | 721 Thousand | -1.23 Million | -479 Thousand |
| Other non-cash items | 1.26 Million | 1.21 Million | 131 Thousand | 131 Thousand | 2.72 Million | 1.45 Million |
| Investing Cash Flow | 27 Thousand | 5000.00 | -159 Thousand | 5000.00 | -43 Thousand | -48 Thousand |
| Investments in PPE | -39 Thousand | -8000.00 | -159 Thousand | 5000.00 | -35 Thousand | -56 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 66 Thousand | 13 Thousand | -2000.00 | 30 Thousand | -8000.00 | 8000.00 |
| Financing Cash Flow | -134 Thousand | -75 Thousand | -1.14 Million | -73 Thousand | -74 Thousand | -928 Thousand |
| Debt repayment | -134 Thousand | -75 Thousand | -294 Thousand | -74 Thousand | -74 Thousand | -74 Thousand |
| Dividends payments | - | - | -799 Thousand | -799 Thousand | - | -799 Thousand |
| Common Stock Repurchased | - | - | -54 Thousand | 1000.00 | - | -55 Thousand |
| Common Stock Issuance | - | - | - | - | 55 Thousand | -55 Thousand |
| Other Financing Activities | -58 Thousand | -75 Thousand | -54 Thousand | 1000.00 | -55 Thousand | - |
| Accounts receivables | 822 Thousand | -191 Thousand | 373 Thousand | 1.27 Million | -595 Thousand | 57 Thousand |
| Accounts payables | -469 Thousand | 379 Thousand | 304 Thousand | -65 Thousand | 11 Thousand | 21 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -357 Thousand | -821 Thousand | -2.4 Million | -487 Thousand | -652 Thousand | -557 Thousand |
| Cash at beginning of period | 1.42 Million | 1.96 Million | 4.75 Million | 1.37 Million | 2.44 Million | 4.38 Million |
| Cash at end of period | 1.43 Million | 1.42 Million | 1.96 Million | 1.96 Million | 1.37 Million | 2.44 Million |
| Capital Expenditure | -39 Thousand | -8000.00 | -159 Thousand | 5000.00 | -35 Thousand | -56 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 13 Thousand | -543 Thousand | -2.78 Million | 594 Thousand | -1.07 Million | -1.93 Million |
| Free Cash Flow | 81 Thousand | -481 Thousand | -1.63 Million | 667 Thousand | -993 Thousand | -1.01 Million |
SYYYF
6358
SCFR
2310
NUWE
BGEU